tm logo
LCB
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 24 Dec 2024

Last Applicant/ Owned by

10, Gukjegwahak 10-ro

Yuseong-gu, Daejeon

KR

34002

Serial Number

98921336 filed on 24th Dec 2024

Registration Number

N/A

Correspondent Address

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.

Phoenix, AZ 85004-2556

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LCB

Vaccines; food supplements; vitamin preparations; crude drugs; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, aut Read More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; food supplements; vitamin preparations; crude drugs; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for medical use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations; cough syrups for pharmaceutical purposes; lozenges for pharmaceutical purposes; cachets for pharmaceutical purposes; chemico-pharmaceutical preparations; antibodies for medical purposes and medical laboratory tests; drugs for medical purposes; medical preparations, namely, antibodies for medical purposes, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, namely, chemical reagents for linking molecules for medical use; pharmaceutical compositions; extracts of medicinal plants, other than essential oils, for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; pharmaceutical products; antibiotics; anti-cancer preparations; mixed vitamin preparations; chemotherapeutics; pharmaceutical preparations for treatment of rare diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98921336

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 89778.04900

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
24th Dec 2024NEW APPLICATION ENTERED